Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$134.56 - $217.97 $160,664 - $260,256
-1,194 Closed
0 $0
Q3 2021

Nov 04, 2021

SELL
$177.8 - $270.58 $22,402 - $34,093
-126 Reduced 9.55%
1,194 $248,000
Q2 2021

Aug 12, 2021

BUY
$121.0 - $257.67 $159,720 - $340,124
1,320 New
1,320 $280,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Quilter PLC Portfolio

Follow Quilter PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

News

Stay updated on Quilter PLC with notifications on news.